The Vox Markets Podcast / Tim Watts, CEO of Shield Therapeutics provides an update on its plans to commercialise Accrufer® in the USA

Our new player has been redesigned to fit in better wherever you embed it. Feedback is welcome on our support site.
You can still use our old player if you prefer.